ClinicalTrials.gg

Eisai Co., Ltd. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 644 studies whose lead sponsor is Eisai Co., Ltd. or one of 7 companies grouped under it. 15 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 11 registry names, not the registry’s. See them and correct one ↓

Compare Eisai with Eli Lilly and GlaxoSmithKline →

Pipeline: 6 programs

Each counted once: 6 with a study Eisai Co., Ltd. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 4 (approved, new studies)

5 from the earlier phases, besides the phase-3 view.

Program
ledasorextonPhase 2 · 2 live · Narcolepsy · primary completion Feb 2027☆ Track
E6742Phase 2 · 1 live · Lupus Erythematosus, Systemic · primary completion Aug 2028☆ Track
E2511Phase 1 · 1 live · Alzheimer Disease · primary completion May 2030☆ Track
E1018Phase 1 · 1 live · Malaria · primary completion Jul 2027☆ Track
DonepezilPhase 4 · 1 live · Alzheimer Disease · primary completion May 2030☆ Track

1 more — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Eisai Co., Ltd.’s own registered studies; Eisai Co., Ltd.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Eisai Co., Ltd.’s studies test, most open studies first — 96 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 96; every drug is on its own page, and each page lists its sponsors.

Coming up

13 of Eisai Co., Ltd.’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 3D
  3. J’27
  4. 1F
  5. 4M
  6. 1A
  7. M
  8. J
  9. 2J
  10. 1A
  11. S
  12. O
  13. 1N

The 12 nearest

Show 7 more

Add all 13 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

Results posted1

Stopped1

All 644 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now152%Recruiting 12 · Not yet recruiting 3
  • Under way, not recruiting183%
  • Completed53483%
  • Stopped early6911%Terminated 56 · Withdrawn 11 · Suspended 2
  • Status unknown or other81%No longer available 4 · Approved for marketing 3 · Available 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 5910
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 826

By the year each study started; 123 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Eisai Co., Ltd..

  • Eisai Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    368 studies
  • Eisai Co., Ltd.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    152 studies
  • Eisai Limited
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    48 studies
  • Eisai Korea Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    31 studies →
  • Morphotek
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    21 studies →
  • EA Pharma Co., Ltd.
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    13 studies →
  • Eisai GmbH
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies
  • Eisai Pharmaceuticals India Pvt. Ltd
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Eisai China Inc.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Eisai Farmacêutica S.A.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • H3 Biomedicine Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Eisai Co., Ltd. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 644. Browse all 644 →